Potentiation by [4,4'-biphenylenebis(2-oxoethylene)]bis-[2,2-diethoxyethyl) dimethylammonium bromide] (DMAE) of the sympathetic component of the vasopressor response to angiotensin.
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D001949:Bretylium Compounds / Q000494:pharmacology; D003042:Cocaine / Q000494:pharmacology; D004285:Dogs; D004357:Drug Synergism; D005260:Female; D006145:Guanethidine / Q000494:pharmacology; D006584:Hexamethonium Compounds / Q000494:pharmacology; D008297:Male; D008638:Mesenteric Arteries / Q000187:drug effects; D009411:Nerve Endings / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011748:Pyrogallol / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D012110:Reserpine / Q000494:pharmacology; D011984:Sensory Receptor Cells / Q000187:drug effects; D014439:Tyramine / Q000494:pharmacology
D001949:Bretylium Compounds; D006584:Hexamethonium Compounds; D000644:Quaternary Ammonium Compounds; D011748:Pyrogallol; D000804:Angiotensin II; D012110:Reserpine; D003042:Cocaine; D009638:Norepinephrine; D014439:Tyramine; D010646:Phentolamine; D006145:Guanethidine